Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | CASP3 | P42574 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.54 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.54 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.51 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.46 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23610037 | 1.00 | MAPT (0.59) | MAPTLMNAGAAHPGDCASP3 | |
| SCHEMBL31143765 | 1.00 | MAPT (0.59) | MAPTLMNAGAAHPGDCASP3 | |
| SCHEMBL31143681 | 1.00 | MAPT (0.59) | MAPTLMNAGAAHPGDCASP3 | |
| SCHEMBL3239740 | 0.84 | LMNA (0.66) | MAPTLMNAGAAHPGDCASP3 | |
| SCHEMBL29608919 | 0.83 | SLC6A3 (0.61) | MAPTLMNAGAACASP3SENP8 | |
| SCHEMBL477506 | 0.82 | LMNA (0.63) | MAPTLMNAGAAHPGDCASP3 | |
| SCHEMBL23882903 | 0.82 | MAPT (0.61) | MAPTLMNAGAAHPGDCASP3 | |
| SCHEMBL23882952 | 0.82 | MAPT (0.61) | MAPTLMNAGAAHPGDCASP3 | |
| SCHEMBL11611302 | 0.81 | SRD5A2 (0.53) | MAPTLMNACYP1A2SLC6A2SLC6A3 | |
| SCHEMBL12475546 | 0.80 | CYP3A4 (0.46) | MAPTLMNAHPGDHTTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11130734-B2 | Amino alcohol-boron-binol complex and method for preparing optically active amino alcohol derivative by using same | MOLECULES & MATERIALS CO., LTD. (KR) | 2021-09-28 | — | — | US | disclosed |
| US-11130734-B2 | Amino alcohol-boron-binol complex and method for preparing optically active amino alcohol derivative by using same | MOLECULES & MATERIALS CO., LTD. (KR) | 2021-09-28 | — | — | US | disclosed |
| US-20210206719-A1 | AMINO ALCOHOL-BORON-BINOL COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE AMINO ALCOHOL DERIVATIVE BY USING SAME | MOLECULES & MATERIALS CO., LTD. (KR) | 2021-07-08 | — | — | US | disclosed |
| US-20210206719-A1 | AMINO ALCOHOL-BORON-BINOL COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE AMINO ALCOHOL DERIVATIVE BY USING SAME | MOLECULES & MATERIALS CO., LTD. (KR) | 2021-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11130734-B2 | Amino alcohol-boron-binol complex and method for preparing optically active amino alcohol derivative by using same | BCAT1, BCAT2, HBS1L | MAPT 2510/4885LMNA 1568/4885GAA 4265/4885 |
| US-20210206719-A1 | AMINO ALCOHOL-BORON-BINOL COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE AMINO ALCOHOL DERIVATIVE BY USING SAME | BCAT1, BCAT2, HBS1L | MAPT 2205/4885LMNA 1810/4885GAA 4278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.